MedPath

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Phase 3
Completed
Conditions
Cocaine-Related Disorders
Registration Number
NCT00000248
Lead Sponsor
Medical University of South Carolina
Brief Summary

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retention
Compliance
Effectiveness of medication for global improvements
Cocaine withdrawal
Drug use
Side effects
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath